Childrens Allergy

Diphenhydramine Hydrochloride


Discount Drug Mart
Human Otc Drug
NDC 53943-505
Childrens Allergy also known as Diphenhydramine Hydrochloride is a human otc drug labeled by 'Discount Drug Mart'. National Drug Code (NDC) number for Childrens Allergy is 53943-505. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Childrens Allergy drug includes Diphenhydramine Hydrochloride - 12.5 mg/5mL . The currest status of Childrens Allergy drug is Active.

Drug Information:

Drug NDC: 53943-505
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Childrens Allergy
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Diphenhydramine Hydrochloride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Discount Drug Mart
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DIPHENHYDRAMINE HYDROCHLORIDE - 12.5 mg/5mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 12 Jan, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part341
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Discount Drug Mart
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1049906
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:TC2D6JAD40
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Histamine H1 Receptor Antagonists [MoA]
Histamine-1 Receptor Antagonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
53943-505-26237 mL in 1 BOTTLE (53943-505-26)12 Jan, 2015N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antihistamine

Product Elements:

Childrens allergy diphenhydramine hydrochloride diphenhydramine hydrochloride diphenhydramine anhydrous citric acid d&c red no. 33 fd&c red no. 40 glycerin poloxamer 407 water sodium benzoate sodium chloride sodium citrate sucrose cherry

Indications and Usage:

Uses temporarily relieves these symptoms due to hay fever or other respiratory allergies: sneezing itching of the nose or throat runny nose itchy watery eyes temporarily relieves these symptoms due to the commom cold: sneezing runny nose

Warnings:

Warnings do not use do not use if printed seal under cap is torn or missing with any other product containing didhenhydramine, even one used on skin to make a child sleepy

When Using:

When using this product marked drowsiness may occur excitability may occur, especially in children sedatives and tranquilizers may increase drowsiness

Dosage and Administration:

Directions if needed, take every 4-6 hours do not take more than 6 doses in 24 hours children under 4 years of age: do not use children 4 to under 6 years of age: do not use unless directed by a doctor children 6 to under 12 years of age: 1 to 2 teaspoonfuls (12.5 mg to 25 mg)

Package Label Principal Display Panel:

Discount drug mart food fair children's allergy product label * compare to the active ingredient in benadryl® allergy liquid discount drug mart food fair children's allergy diphenhydramine hydrochloride antihistamine relieves: sneezing runny nose, itchy water eyes, itchy throat ​alcohol-free cherry flavor 8 fl oz (237 ml) * this product is not manufactured or distributes by mcneil-ppc, inc., distributor of benadryl® allergy liquid. bx-038 satisfaction guaranteed if dissatisfied, return unused portion and package to the store where purchased. if unable to return to the store, send reason for dissatisfaction , name, address and empty package to: discount drug mart, 211 commerce drive medinna, ohio 44256 res aptapharma 505 aptapharma 505 1

Further Questions:

Questions or comments? call weekdays from 9:30 am to 4:30 pm est at 1-877-798-5944.


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.